Andrew J. Budd

Statistics

Publications

Citations

236

H-Index

Active since

1993

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Andrew J. Budd is an author at Memorial Sloan Kettering Cancer Center specializing in metastatic disease treatment, liver metastases treatment, and chemotherapy.

Publications per year

1993–1994

Publications

Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update

Nancy E. Kemeny, Karen Seiter, John A. Conti et al. · Cancer · 1994 · 102 citations

Pharmacy, Oncology, Pharmacology +13

Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.

Nancy E. Kemeny, A Cohen, Karen Seiter et al. · Journal of Clinical Oncology · 1993 · 77 citations

Medicine, Oncology, Pharmacology +17

A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin.A potential adjuvant program after resection of colorectal hepatic metastases

Nancy E. Kemeny, John A. Conti, Elin R. Sigurdson et al. · Cancer · 1993 · 57 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–3 of 3